Status:
UNKNOWN
The Severity Of Individual Breathing Cessation Events In Diagnostics Of Obstructive Sleep Apnea
Lead Sponsor:
Loewenstein Hospital
Collaborating Sponsors:
University of Eastern Finland
Seinajoki Central Hospital
Conditions:
Obstructive Sleep Apnea
Eligibility:
All Genders
16-95 years
Brief Summary
Obstructive sleep apnea (OSA) is a common nocturnal breathing disorder characterized by complete (apnea) and partial (hypopnea) breathing cessations during sleep. Currently, clinical diagnosis of OSA ...
Detailed Description
Obstructive sleep apnea (OSA) is a prevalent nocturnal breathing disorder characterized by complete (apnea) and partial (hypopnea) breathing cessations during sleep 1. OSA is connected to cardiovascul...
Eligibility Criteria
Inclusion
- Good technical quality of polysomnographic (PSG) records
Exclusion
- Bad technical quality of polysomnographic (PSG) records
Key Trial Info
Start Date :
March 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT03232658
Start Date
March 1 2018
End Date
December 1 2020
Last Update
February 28 2019
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Sleep Disorders Centre, Department of Respiratory & Sleep Medicine, Princess Alexandra Hospital, Australia
Brisbane, Australia
2
Department of Applied Physics, University of Eastern Finland
Kuopio, Finland
3
Department of Clinical Neurophysiology, Seinäjoki Central Hospital,
Seinäjoki, Finland
4
Sleep Disorders Unit - Loewenstein Hospital
Raanana, Israel, 43100